» Articles » PMID: 38102104

The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review

Overview
Date 2023 Dec 15
PMID 38102104
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Diet plays an integral role in the modulation of the intestinal environment, with the potential to be modified for management of individuals with inflammatory bowel disease [IBD]. It has been hypothesised that poor 'Western-style' dietary patterns select for a microbiota that drives IBD inflammation and, that through dietary intervention, a healthy microbiota may be restored. This study aimed to systematically review the literature and assess current available evidence regarding the influence of diet on the intestinal microbiota composition in IBD patients, and how this may affect disease activity.

Methods: MEDLINE, EMBASE, Scopus, Web of Science, and Cochrane Library were searched from January 2013 to June 2023, to identify studies investigating diet and microbiota in IBD.

Results: Thirteen primary studies met the inclusion criteria and were selected for narrative synthesis. Reported associations between diet and microbiota in IBD were conflicting due to the considerable degree of heterogeneity between studies. Nine intervention studies trialled specific diets and did not demonstrate significant shifts in the diversity and abundance of intestinal microbial communities or improvement in disease outcomes. The remaining four cross-sectional studies did not find a specific microbial signature associated with habitual dietary patterns in IBD patients.

Conclusions: Diet modulates the gut microbiota, and this may have implications for IBD; however, the body of evidence does not currently support clear dietary patterns or food constituents that are associated with a specific microbiota profile or disease marker in IBD patients. Further research is required with a focus on robust and consistent methodology to achieve improved identification of associations.

Citing Articles

Exploring the connection between erythrocyte membrane fatty acid composition and oxidative stress in patients undergoing the Crohn's disease Therapeutic Diet Intervention (CD-TDI).

Haskey N, Letef C, Sousa J, Yousuf M, Taylor L, McKay D Therap Adv Gastroenterol. 2025; 18:17562848251314827.

PMID: 39963251 PMC: 11831646. DOI: 10.1177/17562848251314827.


From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management.

Naik R, Purcell S, Gold S, Christiansen V, DAloisio L, Raman M Nutrients. 2025; 17(3).

PMID: 39940329 PMC: 11821149. DOI: 10.3390/nu17030470.


Biomarkers of Intestinal Permeability Are Influenced by Diet in Patients with Ulcerative Colitis-An Exploratory Study.

Haskey N, Eisele M, Bruno A, Reimer R, Yousuf M, Taylor L Diagnostics (Basel). 2024; 14(23).

PMID: 39682537 PMC: 11640665. DOI: 10.3390/diagnostics14232629.


The Microbiome in Inflammatory Bowel Disease.

Jauregui-Amezaga A, Smet A J Clin Med. 2024; 13(16).

PMID: 39200765 PMC: 11354561. DOI: 10.3390/jcm13164622.


Healing from Within: How Gut Microbiota Predicts IBD Treatment Success-A Systematic Review.

Alexandrescu L, Nicoara A, Tofolean D, Herlo A, Nelson Twakor A, Tocia C Int J Mol Sci. 2024; 25(15).

PMID: 39126020 PMC: 11313389. DOI: 10.3390/ijms25158451.


References
1.
Forbes A, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S . ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017; 36(2):321-347. DOI: 10.1016/j.clnu.2016.12.027. View

2.
Silva Y, Bernardi A, Frozza R . The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020; 11:25. PMC: 7005631. DOI: 10.3389/fendo.2020.00025. View

3.
Mitrev N, Huang H, Hannah B, Kariyawasam V . Review of exclusive enteral therapy in adult Crohn's disease. BMJ Open Gastroenterol. 2021; 8(1). PMC: 8477235. DOI: 10.1136/bmjgast-2021-000745. View

4.
Sahu P, Kedia S, Vuyyuru S, Bajaj A, Markandey M, Singh N . Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Aliment Pharmacol Ther. 2021; 53(5):568-576. DOI: 10.1111/apt.16249. View

5.
Staudacher H, Lomer M, Farquharson F, Louis P, Fava F, Franciosi E . A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Gastroenterology. 2017; 153(4):936-947. DOI: 10.1053/j.gastro.2017.06.010. View